304 related articles for article (PubMed ID: 20663741)
21. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
22. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
23. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
24. Telomere inhibition and telomere disruption as processes for drug targeting.
Rezler EM; Bearss DJ; Hurley LH
Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745
[TBL] [Abstract][Full Text] [Related]
25. Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.
Crees Z; Girard J; Rios Z; Botting GM; Harrington K; Shearrow C; Wojdyla L; Stone AL; Uppada SB; Devito JT; Puri N
Curr Pharm Des; 2014; 20(41):6422-37. PubMed ID: 24975605
[TBL] [Abstract][Full Text] [Related]
26. Targeting human telomerase by antisense oligonucleotides and ribozymes.
Folini M; Pennati M; Zaffaroni N
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
[TBL] [Abstract][Full Text] [Related]
27. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics.
Zvereva MI; Zatsepin TS; Azhibek DM; Shubernetskaya OS; Shpanchenko OV; Dontsova OA
Biochemistry (Mosc); 2015 Mar; 80(3):251-9. PubMed ID: 25761680
[TBL] [Abstract][Full Text] [Related]
28. [Telomerase inhibitor].
Kyo S; Inoue M
Gan To Kagaku Ryoho; 2001 May; 28(5):614-21. PubMed ID: 11383209
[TBL] [Abstract][Full Text] [Related]
29. Crossroads of telomere biology and anticancer drug discovery.
Seimiya H
Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
[TBL] [Abstract][Full Text] [Related]
30. Telomerase and telomeres: from basic biology to cancer treatment.
Helder MN; Wisman GB; van der Zee GJ
Cancer Invest; 2002; 20(1):82-101. PubMed ID: 11855380
[TBL] [Abstract][Full Text] [Related]
31. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
32. Telomerase and cancer.
Harley CB; Kim NW
Important Adv Oncol; 1996; ():57-67. PubMed ID: 8791128
[TBL] [Abstract][Full Text] [Related]
33. Telomeres and telomerases as drug targets.
Rezler EM; Bearss DJ; Hurley LH
Curr Opin Pharmacol; 2002 Aug; 2(4):415-23. PubMed ID: 12127874
[TBL] [Abstract][Full Text] [Related]
34. Telomere maintenance as a target for drug discovery.
Sekaran V; Soares J; Jarstfer MB
J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
[TBL] [Abstract][Full Text] [Related]
35. Targeted inhibition of telomerase in human cancer: will it be a double-edged sword?
Sasgary S; Wieser M; Cerni C
Onkologie; 2001 Feb; 24(1):22-6. PubMed ID: 11441276
[TBL] [Abstract][Full Text] [Related]
36. Telomeres and telomerases in cancer.
Novak KD
MedGenMed; 2003 Jan; 5(1):21. PubMed ID: 12827082
[No Abstract] [Full Text] [Related]
37. Telomere and telomerase in oncology.
Mu J; Wei LX
Cell Res; 2002 Mar; 12(1):1-7. PubMed ID: 11942406
[TBL] [Abstract][Full Text] [Related]
38. Telomerase inhibitors: targeting the vulnerable end of cancer?
Kelland LR
Anticancer Drugs; 2000 Aug; 11(7):503-13. PubMed ID: 11036953
[TBL] [Abstract][Full Text] [Related]
39. Novel anticancer therapeutics targeting telomerase.
Ruden M; Puri N
Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
[TBL] [Abstract][Full Text] [Related]
40. Harnessing telomerase in cancer therapeutics.
Fakhoury J; Nimmo GA; Autexier C
Anticancer Agents Med Chem; 2007 Jul; 7(4):475-83. PubMed ID: 17630922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
